Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Mironid® Limited logo — Mobkoi specializes in premium mobile marketing using rich me...

Mironid® Limited

Mobkoi specializes in premium mobile marketing using rich media, video, and display to reach premium audiences.

Founded 2015 United Kingdom Glasgow, United Kingdom 16 employees Series B Total: $81.92M Biotechnology, Health Care +3

General Information

Company Name Mironid® Limited
Founded Year 2015
Location United Kingdom Glasgow, United Kingdom +1
Employees 16
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Series B
Social

Get notified when Mironid® Limited moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Mironid® Limited

Mironid® Limited, founded in 2015 and based in the United Kingdom, is making noteworthy advancements in the biotechnology sector. This innovative drug discovery company is pioneering the development of proprietary drug candidate molecules through the modulation of key cell signaling proteins. This unique approach is opening doors across multiple therapeutic areas, with a keen focus on rare genetic kidney diseases.

Recently, Mironid® Limited secured a £30.70M Series A investment on 13 September 2023. This important investment round was driven by a robust consortium of investors, including Sofinnova Partners, BioGeneration Ventures, Scottish Enterprise, EIF, Epidarex Capital, Roche Venture Fund, and the University of Strathclyde. This substantial financial backing reflects strong confidence in the company's unique drug discovery platform and its potential to significantly impact the healthcare landscape.

Taxonomy: mobile marketing, rich media, video advertising, premium audiences, brand experiences, targeted advertising, global publications, local publications, advertising campaigns, audience targeting, reputable advertising, high-end audiences

Services & Products

Development of novel small-molecule therapeutics
Drug pipelines targeting cAMP degrading phosphodiesterase enzymes
Research and development for rare kidney diseases

Target Customers

Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) Individuals with rare kidney diseases Medical professionals and clinicians treating rare kidney conditions

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 6
Investor Investor Investor Investor Investor
•••• •••• 		07 Aug 2026
Series A •••••• 6
Investor Investor Investor Investor Investor
•••• •••• 		01 Sep 2023
Grant •••••• - 01 Mar 2023
Unknown •••••• 1
Investor
01 Jan 2018
Grant •••••• - 01 Jan 2017

View All 7 Funding Rounds

Latest News

View All
Glasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment — Eu-startups
Glasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment
Eu-startups Aug 07, 2026

Mironid® Limited Alternatives & Competitors

View All Alternatives
Mironid® Limited vs
OUTDOOR PLUS LIMITED
OUTDOOR PLUS LIMITED

Leading the creation of London's top digital advertising landmarks to connect with premium audiences...

Private Equity
1 employees
Advertising, Digital Media
Mironid® Limited vs
WEMASS
WEMASS Spain

Transparency, high quality audience in a safe environment.

26 employees
Advertising, Digital Media
Mironid® Limited vs
Carbon Ads
Carbon Ads United States

Connecting advertisers to users through hand-picked publishers, creating targeted verticals filled w...

Seed
2-10 employees
Advertising, Marketing
View all alternatives

FAQ About Mironid® Limited

Mobkoi specializes in premium mobile marketing using rich media, video, and display to reach premium audiences.
Mironid® Limited was founded in 2015.
Mironid® Limited is headquartered in Glasgow, United Kingdom.
Mironid® Limited operates in the following industries: Biotechnology, Health Care, Health and Wellness, Pharmaceutical, Marketing.
Mironid® Limited has approximately 16 employees.
Mironid® Limited has completed 7 funding rounds, raising a total of $81.92M. The latest funding stage is Series B.
Mironid® Limited offers: Development of novel small-molecule therapeutics, Drug pipelines targeting cAMP degrading phosphodiesterase enzymes, Research and development for rare kidney diseases.
Top alternatives and competitors to Mironid® Limited include OUTDOOR PLUS LIMITED, WEMASS, Carbon Ads, Scalify, Dstillery. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mironid® Limited and OUTDOOR PLUS LIMITED are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Mironid® Limited and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy